In the next few days, we should be able to give COVID-19 vaccines to our countrymen, said Union Health Minister Dr Harsh Vardhan after his visit to the session site in Government General Hospital in Chennai to review the second dry run for coronavirus vaccination on Friday.
"In a short time, India has done well by developing vaccines... In the next few days, in the near future, we should be able to give these vaccines to our countrymen. It will be given to our healthcare professional followed by frontline workers," the Minister said.
He added that the government has ensured that every detail regarding vaccination is conveyed to the people from the national level to the grassroots level.
"Lakhs of healthcare workers are being trained through these dry runs, and the process to train more is still going on," Dr Vardhan stated.
The Minister is on a visit to Tamil Nadu to oversee the dry run drill for vaccination. He is scheduled to visit Session Site at government Omandurar hospital in Chennai, vaccination centre at Apollo hospital in Chennai, and vaccination centre in Chengalpattu, Chennai.
The second nationwide mock drill on the COVID-19 vaccination is being held at three-session sites of 736 districts across 33 States/UTs today.
The dry run is aimed at testing the laid out mechanisms for COVID-19 vaccination roll-out in the health system and to assess operational feasibility of using Co-WIN application in a field environment for planning, implementation, and reporting at the block, district, and state level.
According to the health ministry, the objective of the mock drill on COVID-19 vaccination is to simulate the actual vaccine administration event.
On Thursday, Dr Harsh Vardhan had directed all States/Union Territories to be vigilant against rumours and disinformation campaigns regarding the safety and efficacy of the approved COVID-19 vaccines.
Last week, the Drugs Controller General of India announced "restricted emergency use" for Bharat Biotech's 'Covaxin' and Serum Institute of India's 'Covishield', which has been developed by AstraZeneca and Oxford University.
The earlier national mock drill on January 2 helped to iron out any glitches in the final execution and further refinement of the operational procedures. The feedback from most of the States/UTs was satisfactory conduct of the dry run.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU